ASX ANNOUNCEMENT 3 August 2026 Osteopore completes first Hainan custom orthopaedic implantation Australian-Singaporean regenerative medicine company Osteopore Limited ( ASX: OSX ; Osteopore or Company ) – a global leader in 3D-printed biomimetic and...
OSX completes first Hainan custom orthopaedic implant
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Osteopore
- Activities Report June 2026 and Appendix 4C
- OSX secures Hainan FDA approval for orthopaedic devices
- Activities Report March 2026 and Appendix 4C
- Further Drawdown of T2 of the Redeemable Convertible Notes
- Clarification - agreement for injectable regen bone filler
Later from Osteopore
- Details of Auditor Appointment/Resignation
- OSX strikes orthopaedic deal for 5 Middle East countries
- Half Yearly Report and Accounts
- OSX secures market access to Thailand orthopaedic market
- Resignation and appointment of Company Secretary
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore